Allan Reine

Insider Reports History

Entity
Individual
Location
C/O Pieris Pharmaceuticals, Inc., 255 State Street, Boston, MA
Signature
/s/ Karen Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Allan Reine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Financial Officer Common Stock 53.8K $444K $8.25 Jan 16, 2024 Direct
Foghorn Therapeutics Inc. Chief Financial Officer Stock Option (right to buy) 90K $275K $3.06 Jan 16, 2024 Direct
Prime Medicine, Inc. Chief Financial Officer Stock Option (right to buy) 100K May 17, 2024 Direct

Insider Reports Filed by Allan Reine

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. May 17, 2024 1 $0 4 May 21, 2024 Chief Financial Officer
PRME Prime Medicine, Inc. Jan 17, 2024 1 $0 4 Jan 19, 2024 Chief Financial Officer
PRME Prime Medicine, Inc. Jan 17, 2024 0 $0 3 Jan 19, 2024 Chief Financial Officer
FHTX Foghorn Therapeutics Inc. Jan 16, 2024 0 $0 4 Jan 17, 2024 Chief Financial Officer
FHTX Foghorn Therapeutics Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief Financial Officer
FHTX Foghorn Therapeutics Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Financial Officer
FHTX Foghorn Therapeutics Inc. Aug 9, 2021 2 $100K 4 Aug 11, 2021 Chief Financial Officer